Back to search

Article

CD73-derived adenosine at the blood-brain barrier confers protection in a mouse model of ischemic stroke

2026-06-24

Abstract excerpt

<h4>ABSTRACT</h4> Ischemic stroke remains a leading cause of death and disability, and current reperfusion therapies do not address the secondary neuroinflammatory response following blood–brain barrier (BBB) disruption. Purinergic signaling critically regulates this process: extracellular ATP promotes inflammation, whereas its enzymatic conversion into adenosine exerts tissue-protective effects. Notably, the ect...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f25b3fbe-541d-576e-9b78-a3f37d2b95c3
DOI
10.64898/2026.06.19.732935
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD73-derived adenosine at the blood-brain barrier confers protection in a mouse model of ischemic strokeDOI 10.64898/2026.06.19.732935
Select a neighboring publication to make it the new centre.